Abstract:A single atom Gd‐based magnetic resonance imaging (MRI) CA (feGd‐NxC) with concurrently improved relaxivity and stability is fabricated through spatial confined thermal calcination and controllable chemical etching methods. The afforded feGd‐NxC can potentially be utilized as contrast agents both for T1 and T2 weighted MRI, offering self‐confirmative properties for in vivo diagnosis. Gadolinium (Gd)‐based complexes are extensively utilized as contrast agents (CAs) in magnetic resonance imaging (MRI), yet, suffer from potential safety concerns and poor tumor targeting. Herein, as a mimic of Gd complex, single‐atom Gd nanoprobes with r1 and r2 values of 34.2 and 80.1 mM−1 s−1 (far higher than that of commercial Gd CAs) at 3 T are constructed, which possessed T1/T2 dual‐mode MRI with excellent stability and good tumor targeting ability. Specifically, single‐atom Gd is anchored on nitrogen‐doped carbon matrix (Gd‐NxC) through spatial‐confinement method, which is further subjected to controllable chemical etching to afford fully etched bowl‐shape Gd‐NxC (feGd‐NxC) with hydrophilic properties and defined coordination structure, similar to commercial Gd complex. Such nanostructures not only maximized the Gd3+ site exposure, but also are suitable for self‐confirmative diagnosis through one probe with dual‐mode MRI. Moreover, the strong electron localization and interaction between Gd and N atoms afforded feGd‐NxC excellent kinetic inertness and thermal stability (no significant Gd3+ leaching is observed even incubated with Cu2+ and Zn2+ for two months), providing a creative design protocol for MRI CAs.

Noninvasive Diagnosis of Kidney Dysfunction Using a Small-Molecule Manganese-Based Magnetic Resonance Imaging Probe

Detection of Kidney Dysfunction through In Vivo Magnetic Resonance Imaging with Renal-Clearable Gadolinium Nanoprobes

Highly Sensitive Early Diagnosis of Kidney Damage Using Renal Clearable Zwitterion‐Coated Ferrite Nanoprobe via Magnetic Resonance Imaging In Vivo

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

A Biodegradable Bismuth–gadolinium-Based Nano Contrast Agent for Accurate Identification and Imaging of Renal Insufficiency in Vivo

Bioinspired BSA@polydopamine@Fe Nanoprobe with Self-Purification Capacity for Targeted Magnetic Resonance Imaging of Acute Kidney Injury

A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors

Single‐Atom Gd Nanoprobes for Self‐Confirmative MRI with Robust Stability

Magnetic Field-Optimized Paramagnetic Nanoprobe for T 2 / T 1 Switchable Histopathological-Level MRI

Fluorinated 1,7-DO2A-Based Iron(II) Complexes as Sensitive 19F MRI Molecular Probes for Visualizing Renal Dysfunction in Living Mice

Single-point Mutated Lanmodulin As a High-Performance MRI Contrast Agent for Vascular and Kidney Imaging

Red Blood Cell Membrane-Coated Ultrasmall NaGdF 4 Nanoprobes for High-Resolution 3D Magnetic Resonance Angiography

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Magnetic Resonance Angiography with Hour‐Scale Duration after Single Low‐Dose Administration of Biocompatible Gadolinium Oxide Nanoprobe

A Hexanuclear Gadolinium(III)-Based Nanoprobe for Magnetic Resonance Imaging of Tumor Apoptosis

Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging

Biomass-Derived Organonanomaterials As Contrast Agents for Efficient Magnetic Resonance Imaging

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Biocompatibility of Magnetic Resonance Imaging Nanoprobes Improved by Transformable Gadolinium Oxide Nanocoils

Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent.